An MDMA Course Takes 34 Clinician Hours Per Patient
Israel is running MDMA-assisted therapy at a scale the United States is not. A feature in Calcalist lays out what the protocol asks of a clinic. Fifteen sessions over three to four months. One dosing day that runs eight hours. Two therapists in the room the entire time. That is the part American operators should be reading.
Staffing is the whole question in psychedelic delivery, and staffing costs are where a GPO shows up. HealingMaps’ GPO, the first built for the ketamine industry, gets member clinics 40 percent or more off medical supplies, 15 to 20 percent off malpractice and liability premiums, discounted LegitScript certification, and 20 to 30 percent off HIPAA compliant payment processing. Joining is free with no obligation. See what your clinic qualifies for →
| Key Takeaway | Detail |
|---|---|
| The setting | Metiv Center at Herzog Medical Center, with at least 10 MDMA studies running in Israel |
| The course | 15 sessions across three to four months |
| The structure | Three 90-minute prep sessions, one 8-hour dosing session, three more therapy sessions |
| The staffing | Two therapists at every session, one male and one female |
| The arithmetic | Roughly 17 hours of session time per patient, about 34 therapist hours with two in the room |
| The comparison | A Spravato visit runs about two hours of monitoring |
What the Israeli Program Looks Like
The trials are based at the Metiv Center, the Israel Center for the Treatment of Psychotrauma, at Herzog Medical Center. Patients include security personnel and survivors of the October 7 attacks.
Calcalist reports at least 10 MDMA studies underway in the country, covering different populations. The scale reflects need. The report cites roughly 625,000 Israelis living with PTSD.
Interim results are early and should be read that way. Of 60 patients enrolled, 17 had finished treatment, and the report says nearly all no longer met criteria for PTSD.
That is an uncontrolled figure from a small number of completers. It appeared in a news feature, not a published paper. It is encouraging. It is not evidence anyone should quote as a success rate.
The Protocol Is the Story
The course runs three to four months and 15 sessions. Three 90-minute talk therapy sessions come first, then a single dosing session lasting eight hours, then three more therapy sessions.
Two therapists attend every session, one male and one female. That pairing is a deliberate clinical choice in trauma work, and it doubles the labor in every hour.
Add the session hours and a single patient course runs about 17 hours of clinical time. With two clinicians present throughout, that is roughly 34 therapist hours per patient.
Compare That to a Spravato Chair
A Spravato visit involves about two hours of post-dose monitoring. One staff member usually supervises it, and can watch more than one patient.
That difference is not a detail. It is a different business. One model fills a monitoring room efficiently. The other books two licensed clinicians for a full day per patient.
We laid out the underlying math in our piece on session length and chair time. The Israeli protocol is that math with real numbers attached.
Why It Matters Here
MDMA-assisted therapy is back in front of the FDA. We covered the resubmission filed without a new phase 3 trial. Veterans groups have also started backing specific legislation rather than the general idea.
If approval comes, the delivery question lands on interventional psychiatry practices. Those are the sites already positioned for supervised dosing, which is why psilocybin developers are targeting Spravato clinics.
The staffing model is the part that does not transfer. Adding a longer monitoring window is manageable. Adding a second licensed clinician for every hour of every session is a different problem.
The Questions Nobody Has Settled
Who has to be in the room is still open. FDA spent much of its September hearing on training and credentialing. We covered that in our look at the label fight.
Must both clinicians be licensed therapists, or can one be a trained monitor? The answer changes the cost per patient enormously. Labeling will decide it, not preference.
Reimbursement is the other half. Nothing pays for 34 clinician hours at current behavioral health rates. Billing codes matter more here than approval dates.
There is also pressure in the other direction. Providers keep trying to move work out of the clinic. Our data on at-home integration suggests that shift is uneven.
What a Clinic Can Do Now
Nothing here requires action this year. It does reward a practice that starts thinking in clinician hours rather than appointment slots.
Count how many staff hours a full course of treatment consumes today. That number is the baseline any future psychedelic service line gets compared against.
The debate over how much therapy belongs in the protocol is also live. Our look at mostly silent psilocybin sessions covered it. Where that lands changes the staffing question again.
Patients looking for supervised care can start with our directory of verified ketamine clinics.
This article is for informational purposes and is not medical advice. MDMA-assisted therapy is not approved in the United States, and the results described are early and uncontrolled.
